Vir Biotechnology (VIR) Other Non Operating Income (2018 - 2026)

Vir Biotechnology has reported Other Non Operating Income for 9 years, with the latest figure at -$254000.0 in Q1 2026.

• Quarterly Other Non Operating Income fell 252.78% year-over-year to -$254000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$591000.0 (up 70.54% YoY) and the FY2025 annual result came in at -$409000.0, up 81.58% from the prior year.
• Other Non Operating Income rose to -$254000.0 in Q1 2026 per VIR's latest filing, from -$335000.0 in the prior quarter.
• Over five years, Other Non Operating Income peaked at $27.0 million in Q3 2022 and troughed at -$26.2 million in Q4 2022.
• A 5-year average of -$447941.2 and a median of -$287000.0 in 2024 frame the typical range for Other Non Operating Income.
• The widest YoY moves for Other Non Operating Income: up 42128.12% in 2022, down 374000.0% in 2022.
• Over 5 years, Other Non Operating Income stood at -$26.2 million in 2022, then soared by 94.33% to -$1.5 million in 2023, then soared by 65.93% to -$506000.0 in 2024, then jumped by 33.79% to -$335000.0 in 2025, then advanced by 24.18% to -$254000.0 in 2026.
• According to Business Quant data, Other Non Operating Income over the past three periods registered -$254000.0, -$335000.0, and -$228000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.